This article has been cited by
1Cardiac safety of ophthalmic timolol
Jukka Mäenpää,Olavi Pelkonen
Expert Opinion on Drug Safety.2016;15(11)1549
[DOI]
2Complete atrioventricular block due to timolol eye drops: a case report and literature review
Zhuoying Wang,Ian Denys,Feng Chen,Lijie Cai,Xuecui Wang,Daniel R. Kapusta,Yongliang Lv,Juan Gao
BMC Pharmacology and Toxicology.2019;20(1)1549
[DOI]
3Paroxetine Markedly Increases Plasma Concentrations of Ophthalmic Timolol; CYP2D6 Inhibitors May Increase the Risk of Cardiovascular Adverse Effects of 0.5% Timolol Eye Drops
Jukka Mäenpää,Marjo Volotinen-Maja,Hannu Kautiainen,Mikko Neuvonen,Mikko Niemi,Pertti J. Neuvonen,Janne T. Backman
Drug Metabolism and Disposition.2014;42(12)2068
[DOI]
  Feedback 
  Subscribe